African Journal of Urology

Table 3 GSTM1, GSTT1 genotypes distribution among tested patients and healthy controls and susceptibility of PCa

From: Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of prostate cancer in Algerian population

	Patients %	Controls %	OR/CI	P value
M+	43 (42.57)	51(50.49)	/	/
M−	58 (57.42)	50 (49.50)	1.37 [0.76–2.4]	0.26
T+	63 (62.37)	78 (77.22)	/	/
T−	38 (37.62)	23 (22.77)	2.03 [1.06–3.99]	0.03
M +/T+	30 (29.70)	41 (40.59)	/	/
M +/T−	13 (12.87)	10 (9.90)	1.76 [0.62–5.2]	0.33
M−/T+	33 (32.67)	37 (36.63)	1.21 [0.60–2.5]	0.61
M−/T−	25 (24.75)	13 (12.87)	2.6 [1.07–6.5]	0.027

GSTM1 positive (M1 +), GSTM1 null (M1 −), GSTT1 positive (T1 +) and GSTT1 null (T1 −)
OR odds ratios, CI confidence intervals. Wild genotypes were used as a reference (GSTM1 positive, GSTT1 positive)

Back to article page